Karim Khetani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karim Khetani has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Atilla Omeroglu
Department of Pathology
1 shared publication - Brent Zabolotny
10Department of Surgery, Grace General Hospital, 300 Booth Drive, R3J 3M7, Winnipeg, Manitoba, Canada
1 shared publication - Fawaz Halwani
Department of Anatomical Pathology, Sunnybrook Health Sciences Center, 2075 Bayview Avenue, M4N 3M5, Ontario, Canada
1 shared publication - Francois Pepin
Molecular Oncology Group, McGill University Health Centre, 687 Pine Ave, West, H3A 1A1, Quebec, Canada
1 shared publication - Greg Finak
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
1 shared publication - Margarita Souleimanova
Breast Cancer Functional Genomics Group, McGill University, 3775 University Street, H3A 2B4, Montreal, Quebec, Canada
1 shared publication
Latest Publications
- Open Access
- 20 October 2006
- Published by Springer Nature in Breast Cancer Research
- Vol. 8 (5) , R58
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
Introduction: The role of the cellular microenvironment in breast tumorigenesis has become an important research area. However, little is known about gene expression in histologically normal tissue adjacent to breast tumor, if this is influenced by the tumor, and how this compares with non-tumor-bearing breast tissue. Methods: To address this, we have generated gene expression profiles of morphologically normal epithelial and stromal tissue, isolated using laser capture microdissection, from patients with breast cancer or undergoing breast reduction mammoplasty (n = 44). Results: Based on this data, we determined that morphologically normal epithelium and stroma exhibited distinct expression profiles, but molecular signatures that distinguished breast reduction tissue from tumor-adjacent normal tissue were absent. Stroma isolated from morphologically normal ducts adjacent to tumor tissue contained two distinct expression profiles that correlated with stromal cellularity, and shared similarities with soft tissue tumors with favorable outcome. Adjacent normal epithelium and stroma from breast cancer patients showed no significant association between expression profiles and standard clinical characteristics, but did cluster ER/PR/HER2-negative breast cancers with basal-like subtype expression profiles with poor prognosis. Conclusion: Our data reveal that morphologically normal tissue adjacent to breast carcinomas has not undergone significant gene expression changes when compared to breast reduction tissue, and provide an important gene expression dataset for comparative studies of tumor expression profiles.
- 20 October 2006
- Published by Springer Nature in Breast Cancer Research
- Vol. 8 (5) , R58
Open AccessGene expression signatures of morphologically normal breast tissue identify basal-like tumors
Introduction: The role of the cellular microenvironment in breast tumorigenesis has become an important research area. However, little is known about gene expression in histologically normal tissue adjacent to breast tumor, if this is influenced by the tumor, and how this compares with non-tumor-bearing breast tissue. Methods: To address this, we have generated gene expression profiles of morphologically normal epithelial and stromal tissue, isolated using laser capture microdissection, from patients with breast cancer or undergoing breast reduction mammoplasty (n = 44). Results: Based on this data, we determined that morphologically normal epithelium and stroma exhibited distinct expression profiles, but molecular signatures that distinguished breast reduction tissue from tumor-adjacent normal tissue were absent. Stroma isolated from morphologically normal ducts adjacent to tumor tissue contained two distinct expression profiles that correlated with stromal cellularity, and shared similarities with soft tissue tumors with favorable outcome. Adjacent normal epithelium and stroma from breast cancer patients showed no significant association between expression profiles and standard clinical characteristics, but did cluster ER/PR/HER2-negative breast cancers with basal-like subtype expression profiles with poor prognosis. Conclusion: Our data reveal that morphologically normal tissue adjacent to breast carcinomas has not undergone significant gene expression changes when compared to breast reduction tissue, and provide an important gene expression dataset for comparative studies of tumor expression profiles.